| Company Name: |
TargetMol |
| Tel: |
400-821-0310 15002144251 |
| Email: |
xuexiang.shao@tsbiochem.com |
|
| | 9H-Carbazole-9-pentanaminium, 3,6-dibromo-N,N,N-trimethyl-, chloride (1:1) Basic information |
| Product Name: | 9H-Carbazole-9-pentanaminium, 3,6-dibromo-N,N,N-trimethyl-, chloride (1:1) | | Synonyms: | 9H-Carbazole-9-pentanaminium, 3,6-dibromo-N,N,N-trimethyl-, chloride (1:1);Tapencarium | | CAS: | 1436920-57-8 | | MF: | C20H25Br2ClN2 | | MW: | 488.69 | | EINECS: | | | Product Categories: | | | Mol File: | 1436920-57-8.mol |  |
| | 9H-Carbazole-9-pentanaminium, 3,6-dibromo-N,N,N-trimethyl-, chloride (1:1) Chemical Properties |
| | 9H-Carbazole-9-pentanaminium, 3,6-dibromo-N,N,N-trimethyl-, chloride (1:1) Usage And Synthesis |
| Uses | Tapencarium (RZL-012) is a serine/threonine kinase inhibitor. Tapencarium can reduce subcutaneous fat volume. Tapencarium is promising for research of fat-related disorders such as Dercum’s disease and aesthetic applications[1]. | | References | [1] Shridharani SM, et al. Efficacy and Safety of Tapencarium (RZL-012) in Submental Fat Reduction. Aesthet Surg J. 2023 Sep 14;43(10):NP797-NP806. DOI:10.1093/asj/sjad195 |
| | 9H-Carbazole-9-pentanaminium, 3,6-dibromo-N,N,N-trimethyl-, chloride (1:1) Preparation Products And Raw materials |
|